| FMCEX | FSMAX | FMCEX / FSMAX | |
| Total Expense Ratio | 1.68 | 0.04 | 4,800% |
| Annual Report Gross Expense Ratio | 1.68 | 0.04 | 4,800% |
| Fund Existence | 28 years | 14 years | - |
| Gain YTD | 3.678 | 6.349 | 58% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 41.5B | 5% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | -2.26 | 4.46 | -51% |
| Returns for 3 years | 15.20 | 49.71 | 31% |
| Returns for 5 years | 11.71 | 33.47 | 35% |
| Returns for 10 years | 27.56 | 93.83 | 29% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VSFRX | 23.88 | 0.06 | +0.25% |
| Federated Hermes Clover Small Value R | |||
| WIAEX | 37.99 | 0.05 | +0.13% |
| Wasatch Small Cap Growth Institutional | |||
| JFNNX | 81.84 | 0.09 | +0.11% |
| Janus Henderson Global Life Sciences N | |||
| DRTCX | 21.44 | N/A | N/A |
| BNY Mellon Sust US Equity I | |||
| MSVMX | 6.13 | N/A | N/A |
| Morgan Stanley Vitality Portfolio C | |||